news.bloombergtax.com
Many companies will keep capitalizing their US research and development expenses and not take advantage of provisions allowing immediate expensing in the new GOP tax law, to avoid exposure to the 15% corporate alternative minimum tax, a vice president at Johnson & Johnson said.
30 days ago